Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Director Declaration

1 Oct 2019 11:47

RNS Number : 3586O
Zotefoams PLC
01 October 2019
 

Zotefoams plc

(the 'Company')

 

 

 

 

Director Declaration

In accordance with Listing Rule 9.6.14 (2), the Company announces that Angela Bromfield, non-executive director, has been appointed non-executive director of Marshalls plc with effect from 1 October 2019.

Enquiries:

 

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

1 October 2019

 

 

 

 

 

 

About Zotefoams plc:

 

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA, to customers worldwide.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell® Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNFSMFSFFUSELS
Date   Source Headline
26th Mar 20248:36 amRNSReplacement Notice Transactions Of Directors/PDMRs
26th Mar 20247:00 amRNSGroup CEO succession
25th Mar 20245:58 pmRNSNotification Of Transactions Of Directors/PDMRs
22nd Mar 20245:31 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSPreliminary Results
12th Mar 20241:41 pmRNSNotification Of Transactions Of Directors/PDMRs
14th Feb 20247:00 amRNSZotefoams joins independent authority, RECOUP
13th Feb 202412:31 pmRNSNotification Of Transactions Of Directors/PDMRs
7th Feb 20247:00 amRNSNotice of results and investor presentation
5th Feb 20241:20 pmRNSHolding(s) in Company
22nd Jan 20241:58 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSFull Year Trading Update
12th Jan 20245:13 pmRNSDirector/PDMR Shareholding
12th Jan 202412:28 pmRNSNotification Of Transactions Of Directors/PDMRs
5th Jan 202412:47 pmRNSReplacement Holding(s) in Company
4th Jan 20243:24 pmRNSHolding(s) in Company
4th Jan 20241:17 pmRNSHolding(s) in Company
13th Dec 20234:49 pmRNSHolding(s) in Company
13th Dec 20234:31 pmRNSReplacement Notice Transactions Of Directors/PDMRs
13th Dec 20231:54 pmRNSHolding(s) in Company
12th Dec 20233:46 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Dec 202312:45 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Dec 20231:53 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Nov 20237:00 amRNSTop industry award for ReZorce® beverage cartons
14th Nov 202311:56 amRNSNotification Of Transactions Of Directors/PDMRs
8th Nov 20235:38 pmRNSHolding(s) in Company
7th Nov 20237:01 amRNSGroup CEO succession
7th Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSZotefoams programme extension at Nike
12th Oct 202312:09 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Oct 20239:47 amRNSNotification Of Transactions Of Directors/PDMRs
29th Sep 20237:00 amRNSBoard Changes
18th Sep 20234:45 pmRNSHolding(s) in Company
12th Sep 202310:57 amRNSNotification Of Transactions Of Directors/PDMRs
5th Sep 20234:07 pmRNSHolding(s) in Company
31st Aug 20233:14 pmRNSHolding(s) in Company
29th Aug 20237:00 amRNSInvestor presentation on Investor Meet Company
25th Aug 20237:00 amRNSIssue of Equity
14th Aug 20231:51 pmRNSNotification of Transactions of Directors/PDMRs
9th Aug 20233:29 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSInterim Results
19th Jul 20231:29 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSJoint development agreement for ReZorce®
12th Jul 202311:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th Jul 20237:00 amRNSNotice of results and investor presentation
22nd Jun 20232:20 pmRNSHolding(s) in Company
20th Jun 202310:16 amRNSNotification Of Transactions Of Directors/PDMRs
14th Jun 20237:00 amRNSHolding(s) in Company
13th Jun 20232:55 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
6th Jun 20231:34 pmRNSNotification Of Transactions Of Directors/PDMRs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.